- Home
- ZLAB vs RNST Comparison
ZLAB vs RNST Comparison
Compare ZLAB & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | RNST |
|---|---|---|
| Founded | 2013 | 1904 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.6B |
| IPO Year | 2017 | 1997 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | RNST |
|---|---|---|
| Price | $25.53 | $39.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 7 |
| Target Price | $33.14 | ★ $48.14 |
| AVG Volume (30 Days) | ★ 698.4K | 522.0K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 2.47% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ 1.88 |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | N/A | $12.18 |
| Revenue Next Year | $26.50 | $3.21 |
| P/E Ratio | ★ N/A | $21.00 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $33.04 |
| 52 Week High | $34.07 | $44.54 |
Technical Indicators
Market Signals| Indicator | ZLAB | RNST |
|---|---|---|
| Relative Strength Index (RSI) | 58.51 | 27.31 |
| Support Level | $24.81 | $35.04 |
| Resistance Level | $27.20 | $40.84 |
| Average True Range (ATR) | 0.77 | 0.66 |
| MACD | -0.03 | -0.13 |
| Stochastic Oscillator | 76.31 | 0.00 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.